Advancing Precision Oncology: New NGS Assay for Comprehensive Genomic Profiling

Agilent Technologies Inc has unveiled the Agilent SureSelect Cancer CGP Assay, a next-generation sequencing (NGS) panel designed for somatic variant profiling in a wide range of solid tumour types. Click to read more...

Related Keywords

Glasgow ,Glasgow City ,United Kingdom ,Alistair Ritchie ,Ronda Allen ,Glasgow Precision Oncology Laboratory ,Agilent Technologies Inc ,Genomics Division At Agilent ,Agilent Sureselect Cancer ,Sureselect Cancer ,Alissa Interpret ,Vice President ,General Manager ,Genomics Division ,Sequencing Laboratory Manager ,Agilent Sureselect ,Cancer ,Agilent ,Sureselect ,Biomarkers ,Profiling ,Olid ,Humour ,Linical ,Comprehensive ,Workflow ,